November 2016
A triple therapy approach to Type 1 diabetes
Type 1 diabetes treatment doesn't have to be about just insulin anymore. There are many new medications on the market aimed at treating Type 2 that provide glucose control through various pathways. Type 1 management is starting to incorporate some of these agents for improving glucose control.
OmniPod Artificial Pancreas System Clinical Trial
If you are interested in participating in a study involving the use of the OmniPod Horizon Hybrid Closed Loop System, you might want to check out ClinicalTrials.gov to see if you qualify
Macrovascular complications related to A1c in longstanding Type 1 diabetes
According to research published in the September, 2016 issue of Diabetic Medicine, A1c levels are a predictor of macrovascular disease, independent of diabetes duration. Wait a minute--didn't we think that A1c doesn't predict cardiovascular complications?
Abbott gets premarket approval from FDA for FreeStyle Libre Pro
Folks with diabetes in the USA may or may not be aware that in other parts of the world, people with diabetes are using the Abbott Libre. It's a form of CGM (Continuous Glucose Monitoring) that doesn't provide alarms for out of range blood glucose (BG) levels, but it also doesn't need to be calibrated in order to track BG levels, and a sensor is worn for two weeks.
November’s Survey – What are you most thankful for?
View the results of last month's survey and VOTE a new November survey!
Switching Diet Drinks for Water Benefits Overweight Women
A Danish study examines the link between vitamin D and cardiovascular autonomic neuropathy associated with diabetes.
Danish study on vitamin D, diabetes and heart disease
A Danish study examines the link between vitamin D and cardiovascular autonomic neuropathy associated with diabetes.